Condition: Chemotherapy-induced Peripheral Neuropathy · Pain, Neuropathic · Pain Syndrome · Sponsor: Bernardino Clavo, MD, PhD
The main objective of this clinical trial is to evaluate the effectiveness and cost-effectiveness of adding ozone therapy to the clinical management of patients with pain secondary to chemotherapy-induced peripheral neuropathy
This description comes directly from the study's public registry record.
Bernardino Clavo, MD, PhD · (34)928449278 · bernardinoclavo@gmail.com
Delvys Rodríguez-Abreu, MD · (34)928441779 · drodabr@gobiernodecanarias.org
Always discuss trial participation with your own doctor first.
| Complejo Hospitalario Materno Insular | Las Palmas de Gran Canaria, Las Palmas, Spain | Recruiting |
| Hospital Universitario de Gran Canaria Dr. Negrín | Las Palmas de Gran Canaria, Las Palmas, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04299893